Clinical and epidemiological differences between men and women with systemic sclerosis: a study in a Spanish systemic sclerosis cohort and literature review.

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Clinical and Experimental Rheumatology

• Publication date

  2017-09-01

• Fields of study

  Medicine

• Identifiers
  PMID 28980905
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Occupational and environmental scleroderma. Systematic review and meta-analysis

  2017cited by this paper
• Very early and early systemic sclerosis in the Spanish scleroderma Registry (RESCLE) cohort.

  2017cited by this paper
• Gender differences in systemic sclerosis: relationship to clinical features, serologic status and outcomes

  2016cited by this paper
• One year in review 2016: systemic sclerosis.

  2016cited by this paper
• Sex disparities in systemic sclerosis-associated pulmonary arterial hypertension: a cohort study

  2016cited by this paper
• Examination of the association of sex and race/ethnicity with appearance concerns: a Scleroderma Patient-centered Intervention Network (SPIN) Cohort study.

  2016cited by this paper
• Prediction risk chart for scleroderma digital ulcers: A composite predictive model based on capillaroscopic, demographic and clinico-serological parameters

  2015cited by this paper
• Antinuclear antibody-negative systemic sclerosis.

  2015influential reference
• The Effect of Male Sex on Survival in Systemic Sclerosis

  2014influential reference
• Early- versus Late-Onset Systemic Sclerosis

  2014cited by this paper
• No association of atherosclerosis with digital ulcers in Japanese patients with systemic sclerosis: Evaluation of carotid intima‐media thickness and plaque characteristics

  2014cited by this paper
• A gender gap in primary and secondary heart dysfunctions in systemic sclerosis: a EUSTAR prospective study

  2014cited by this paper
• Mortality and survival in systemic sclerosis: systematic review and meta-analysis.

  2014cited by this paper
• The Sex Bias in Systemic Sclerosis: on the Possible Mechanisms Underlying the Female Disease Preponderance

  2014cited by this paper
• Is Vasculopathy Associated with Systemic Sclerosis More Severe in Men?

  2013cited by this paper
• Systemic Sclerosis in Canada’s North American Native Population: Assessment of Clinical and Serological Manifestations

  2013cited by this paper
• Age at onset and gender distribution of systemic lupus erythematosus, polymyositis/dermatomyositis, and systemic sclerosis in Japan

  2013influential reference
• An integrated approach in the diagnosis of smoking-related interstitial lung diseases

  2012cited by this paper
• Survival, Causes of Death, and Prognostic Factors in Systemic Sclerosis: Analysis of 947 Brazilian Patients

  2012influential reference
• Epidemiology of Systemic Sclerosis in a Large US Managed Care Population

  2012cited by this paper
• Registry of the Spanish network for systemic sclerosis: clinical pattern according to cutaneous subsets and immunological status.

  2012cited by this paper
• [Special features of systemic sclerosis in men].

  2012influential reference
• Registries in systemic sclerosis: a worldwide experience.

  2011cited by this paper
• Association of Gender with Clinical Expression, Quality of Life, Disability, and Depression and Anxiety in Patients with Systemic Sclerosis

  2011cited by this paper
• Causes and risk factors for death in systemic sclerosis: a study from the EULAR Scleroderma Trials and Research (EUSTAR) database

  2010cited by this paper
• Age-related survival and clinical features in systemic sclerosis patients older or younger than 65 at diagnosis.

  2010cited by this paper
• Determinants of morbidity and mortality of systemic sclerosis in Canada.

  2010cited by this paper
• Comparison of patients with and without digital ulcers in systemic sclerosis: detection of possible risk factors

  2009cited by this paper
• Time to diagnosis in systemic sclerosis: is sex a factor?

  2009cited by this paper
• Systemic Sclerosis in Northwestern Spain: A 19-year Epidemiologic Study

  2008influential reference
• [Systemic sclerosis in men].

  2008cited by this paper
• Endothelin and sex hormones modulate the fibronectin synthesis by cultured human skin scleroderma fibroblasts

  2008cited by this paper
• [Interstitial lung disease in systemic sclerosis].

  2007cited by this paper
• Natural history of ischemic digital ulcers in systemic sclerosis: single-center retrospective longitudinal study.

  2007cited by this paper
• Digital ulcers: overt vascular disease in systemic sclerosis.

  2006cited by this paper
• Prolactin synthesis by lymphocytes from patients with systemic sclerosis.

  2006cited by this paper
• Epidemiology of systemic sclerosis in northwest Greece 1981 to 2002.

  2005cited by this paper
• Prolactin and thyroid hormones in patients with systemic sclerosis: correlations with disease manifestations and activity

  2002cited by this paper
• Systemic sclerosis: demographic, clinical, and serologic features and survival in 1,012 Italian patients.

  2002cited by this paper
• Somatic symptom reporting in women and men

  2001cited by this paper
• Survival prognostic factors and markers of morbidity in Spanish patients with systemic sclerosis

  1997influential reference
• Incidence of systemic sclerosis in Allegheny County, Pennsylvania. A twenty-year study of hospital-diagnosed cases, 1963-1982.

  1997cited by this paper
• Systemic sclerosis in men: clinical and immunological differences.

  1996cited by this paper
• Wide-field capillary microscopy.

  1981influential reference

• Impact of male sex in clinical and laboratory features of systemic sclerosis

  2026cites this paper
• Gastrointestinale Manifestationen bei systemischer Sklerose

  2025cites this paper
• [Frequency of hypogonadism and clinical features of systemic sclerosis and idiopathic inflammatory myopathies in men depending on testosterone levels].

  2025cites this paper
• Sex differences in systemic sclerosis: from pathogenesis to clinical manifestations and treatment

  2025cites this paper
• Residence at high altitude as a risk factor for high probability of pulmonary hypertension in patients with systemic sclerosis: A case-control study.

  2025cites this paper
• Connective tissue disease-related interstitial lung disease and pulmonary hypertension

  2025cites this paper
• Untangling the relationship between smoking and systemic sclerosis: an analysis of the EUSTAR cohort

  2024cites this paper
• Pulmonary involvement in systemic sclerosis: can sex play a role?

  2024cites this paper
• Pulmonary and extra-pulmonary effects of lung transplantation in an Italian cohort of patients with systemic sclerosis.

  2024cites this paper
• Assessing hand and global disability in a cohort of Algerian patients with systemic sclerosis: Construct validities of the Arab Hand Function Index and the Arabic Health Assessment Questionnaire

  2024cites this paper
• Progression from suspected to definite systemic sclerosis and the role of anti-topoisomerase I antibodies

  2023cites this paper
• Heterogeneity of determining disease severity, clinical course and outcomes in systemic sclerosis-associated interstitial lung disease: a systematic literature review

  2023cites this paper
• Características de los pacientes con esclerosis sistémica que desarrollan enfermedad pulmonar intersticial

  2023cites this paper
• Sex bias in immune response: it is time to include the sex variable in studies of autoimmune rheumatic diseases.

  2023cites this paper
• Can Pharmacogenetic Variants in TPMT, MTHFR and SLCO1B1 Genes Be Used as Potential Markers of Outcome Prediction in Systemic Sclerosis Patients?

  2023cites this paper
• Step forward in early recognition of systemic sclerosis: data from the Leiden CCISS cohort

  2023cites this paper
• Impact of Innovative Treatment Using Biological Drugs for the Modulation of Diffuse Cutaneous Systemic Sclerosis: A Systematic Review

  2023cites this paper
• Worsening premature death burden gap from systemic sclerosis in men and black persons: A US nationwide population-based study

  2022cites this paper
• Mesenchymal Stem Cell–Based Therapy as a New Approach for the Treatment of Systemic Sclerosis

  2022cites this paper
• Systemic sclerosis mortality trends in Spain from 1980 to 2019: age–period–cohort and joinpoint analysis

  2022cites this paper
• Standardized incidence ratios and risk factors for cancer in patients with systemic sclerosis: Data from the Spanish Scleroderma Registry (RESCLE).

  2022cites this paper
• Sex-specific risk of anti-topoisomerase antibodies on mortality and disease severity in systemic sclerosis: 10-year analysis of the Leiden CCISS and EUSTAR cohorts.

  2022cites this paper
• The impact of sex and anti-topoisomerase I antibodies in systemic sclerosis.

  2022cites this paper
• Associations of autoantibodies and clinical profile of the patients with systemic sclerosis

  2022cites this paper
• Sex influence on outcomes of patients with systemic sclerosis-associated interstitial lung disease: an EUSTAR database analysis.

  2022cites this paper
• Damage Trajectories in Systemic Sclerosis Using Group‐Based Trajectory Modeling

  2022cites this paper
• PH-ILD: Identification, Evaluation, and Monitoring: A Diagnostic View From Both Sides

  2021cites this paper
• Gender differences in clinical features and outcomes of a Portuguese systemic sclerosis cohort

  2021cites this paper
• Independent association between occupational exposure and decline of forced vital capacity in systemic sclerosis (SSc): a multicenter recruitment retrospective cohort study.

  2021cites this paper
• Sine scleroderma, limited cutaneous, and diffused cutaneous systemic sclerosis survival and predictors of mortality

  2021cites this paper
• Pulmonary hypertension in interstitial lung disease: screening, diagnosis and treatment

  2021cites this paper
• Association between Appendicitis and Incident Systemic Sclerosis

  2021cites this paper
• Connective Tissue Disease, Interstitial Lung Disease, and Pulmonary Hypertension (CTD PH-ILD): A Distinct Entity and Potential Opportunity

  2021cites this paper
• Gender differences in organ involvement and survival in systemic sclerosis – experience of a EUSTAR center

  2021cites this paper
• Gender-related differences in systemic sclerosis.

  2020influential citation
• Sex hormones and sex hormone-targeting therapies in systemic sclerosis: A systematic literature review.

  2020influential citation
• Contribution of Sex and Autoantibodies to Microangiopathy Assessed by Nailfold Videocapillaroscopy in Systemic Sclerosis: A Systematic Review of the Literature

  2020influential citation
• Quantificação do dano ao DNA mitocondrial e número de cópias no sangue circulante de pacientes com esclerose sistêmica em um ensaio baseado em qPCR

  2020cites this paper
• Systemic sclerosis: Update for oral health care providers.

  2020cites this paper
• Quantification of mitochondrial DNA damage and copy number in circulating blood of patients with systemic sclerosis by a qPCR-based assay☆☆☆

  2020cites this paper
• Systemic sclerosis Progression INvestiGation (SPRING) Italian registry: demographic and clinico-serological features of scleroderma spectrum.

  2020cites this paper
• Comparison of clinical presentation and incidence of cardiopulmonary complications between male and female Thai patients with early systemic sclerosis: inception cohort study

  2019influential citation
• Exploring the patient experience of digital ulcers in systemic sclerosis.

  2019cites this paper
• Inflammatory stays inflammatory: a subgroup of systemic sclerosis characterized by high morbidity and inflammatory resistance to cyclophosphamide

  2019cites this paper
• Estradiol levels are elevated in older men with diffuse cutaneous SSc and are associated with decreased survival

  2019cites this paper
• Unraveling SSc Pathophysiology; The Myofibroblast

  2018cites this paper
• Update on the epidemiology, risk factors, and disease outcomes of systemic sclerosis.

  2018cites this paper